State of New Jersey Common Pension Fund D - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,345,607
-12.6%
94,7720.0%0.01%
-11.1%
Q2 2023$2,683,943
+33.5%
94,772
+8.3%
0.01%
+28.6%
Q1 2023$2,010,748
-11.4%
87,538
+8.3%
0.01%
-22.2%
Q4 2022$2,268,724
-7.1%
80,795
-6.4%
0.01%
-10.0%
Q3 2022$2,442,000
-4.2%
86,349
-1.4%
0.01%
+25.0%
Q1 2022$2,549,000
+5.5%
87,567
+19.2%
0.01%
+14.3%
Q4 2021$2,415,000
-16.7%
73,486
+17.0%
0.01%
-22.2%
Q3 2021$2,898,000
+16.9%
62,806
+39.7%
0.01%
+12.5%
Q2 2021$2,478,000
+13.2%
44,961
+6.0%
0.01%0.0%
Q1 2021$2,189,000
-16.7%
42,398
-30.1%
0.01%
-11.1%
Q4 2020$2,627,000
+30.5%
60,622
+5.4%
0.01%
+12.5%
Q3 2020$2,013,000
-18.0%
57,525
+25.3%
0.01%
-20.0%
Q2 2020$2,456,000
+8.1%
45,926
-28.3%
0.01%
-9.1%
Q1 2020$2,272,000
-25.7%
64,0280.0%0.01%
-8.3%
Q4 2019$3,057,000
+85.4%
64,028
+25.8%
0.01%
+100.0%
Q3 2019$1,649,00050,9000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders